Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Use antiandrogens and other treatments for hair loss.

Lophocereus marginatus extracts may help treat melanoma and stimulate hair growth.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Mast cells likely promote skin scarring and fibrosis, but their exact role is still unclear.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

Targeting the PGD2-DP2 pathway may help treat hair loss.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

Minoxidil boosts hair growth by opening potassium channels and increasing cell activity.

Juniperus plants contain compounds with potential for developing various medical treatments.

Ulcerative colitis involves immune activation, chronic inflammation, and metabolic issues, some of which persist even during remission.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Human hair follicles can make and process prostaglandins, which may affect hair growth.

The leaves of Platycladus orientalis have potential health benefits but require more research for safety and understanding how they work.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

CXXC5 is a protein that prevents hair growth and could be a target for hair loss treatment.

Bruguiera gymnorhiza leaf extracts show potential for developing anti-inflammatory drugs.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Ion sequential therapy improves heart function after a heart attack.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.